Rationale: Randomized controlled trials of continuous positive airway pressure (CPAP) in
patients with obstructive sleep apnea (OSA) have not demonstrated protection against …

Question: Is continuous positive airway pressure (CPAP) therapy better than no therapy in
reducing the incidence of hypertension or cardiovascular (CV) events in a cohort of …

Three recent randomized control trials (RCTs) found that treatment of obstructive sleep
apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future …

Purpose The associations between obstructive sleep apnea (OSA) and all-cause and
cardiovascular mortality are well established but are not entirely consistent. To accurately …

Obstructive sleep apnea (OSA) is a common condition in patients with cardiovascular
diseases (CVD). The first line treatment of OSA is continuous positive airway pressure …

Background: Association between untreated obstructive sleep apnea (OSA) and
cardiovascular disease (CVD) is well known. In this literature review, we aim to review the …

The epidemiological and randomized clinical studies show that obstructive sleep apnea
syndrome (OSA) is a common, risk factor of cardiovascular disease which can be treated …

Until recently, treatment for obstructive sleep apnea (OSA) was not a controversial topic.
Untreated OSA is associated with increased rate of myocardial infarction, stroke …

Obstructive sleep apnea is a common disorder with increased risk for cardiovascular
morbidity and mortality. The first choice of treatment of obstructive sleep apnea is continuous …

1. Giugliano RP, Cannon CP, Blazing MA, et al. Benefit of adding ezetimibe to statin therapy
on cardiovascular outcomes and safety in patients with versus without diabetes Mellitus …